GLP-1 Weight Loss Drugs: What Ozempic and Mounjaro Actually Do to Your Body
GLP-1 receptor agonists — the drug class that includes Ozempic, Wegovy, and Mounjaro — have become the most talked-about medications in America. But most people don’t understand how they actually work.
What Is a GLP-1?
GLP-1 (glucagon-like peptide-1) is a hormone your body naturally produces after you eat. It signals to your brain: “you’re full.” GLP-1 drugs mimic this hormone, dramatically amplifying and extending that “full” signal.
What Happens in Your Body
Within hours of an injection:
- Your stomach empties more slowly — food sits there longer, keeping you full
- Insulin production increases, lowering blood sugar
- Glucagon is suppressed (glucagon raises blood sugar)
- Brain signals for hunger and “food noise” are significantly reduced
The Weight Loss Numbers
Clinical trials show:
- Ozempic/Wegovy (semaglutide): Average 15–17% body weight loss over 68 weeks
- Mounjaro/Zepbound (tirzepatide): Average 20–22% body weight loss — the most effective yet approved
The Side Effects
The most common: nausea, vomiting, diarrhea, constipation. These usually improve after the first few months. Rare but serious risks include pancreatitis and, in animal studies (not human), thyroid tumors.
Who Should Take Them?
These drugs are FDA-approved for adults with a BMI of 30+ (or 27+ with weight-related conditions). They require a prescription and are most effective combined with diet and exercise changes.
📌 Source: FDA, New England Journal of Medicine. Not medical advice.